Zurueck zur Suche

Reporte zur Charge U025791

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 5 MN 1 IN 1 NE 1 NY 1 PR 1 OH 1

VAERS 2619875

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
MN
Alter
63,0
Geschlecht
F
Eingang
24.04.2023
Impfdatum
21.04.2023
Beginn
21.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Unevaluable event

Symptomtext

None

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Osteoarthritis, Urge Incontinence, COPD, GERD, Rectocele, Cystocele, Hyperlipidemia
Andere Medikamente
Nicotine Patch
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2355657

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IN
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No further adverse events; Nurse reporting administered dose of expired DILUENT.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not provided. On 15-JUN-2022, the patient was vaccinated with one dose of varicella virus vaccine live (VARIVAX) as prophylaxis (strength, frequency, route of administration, and anatomical injection site were not reported; lot number U025791 with an expiration date of 19-AUG-2023). The vaccine was reconstituted with one dose of an expired sterile diluent (lot number S026378 with an expiration date of 15-MAY-2022) (expired product administered). No further adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2328232

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
23.06.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation issue

Symptomtext

No additional adverse event were reported; Office manager reported that a patient received an improperly stored VARIVAX that was reconstituted with properly stored sterile diluent; This spontaneous report has been received from office manager, regarding a patient of unknown gender and age. The patient's concurrent conditions, medical history and concomitant therapies were not reported On 11-APR-2022, the patient was vaccinated with first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U025791 has been verified to be valid, expiration date 19-AUG-2023) (dose regimen, route of administration and anatomical location were not reported), reconstituted with properly stored Merck sterile diluent (lot# and expiration date were not provided) administered for prophylaxis. It was reported that the varicella virus vaccine live (oka/merck) (VARIVAX) underwent a temperature excursion of 6 Fahrenheit (?F) up to 14 ?F for 15 minutes and 14 ?F up to 46 ?F (average temperature 34.93 ?F) for 1 hours and 15 minutes (product storage error). There was no previous temperature excursion. Not adverse events (AE) were reported, and no further information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2321437

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
16.06.2022
Impfdatum
15.04.2022
Beginn
15.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No addiitional AE were reported; Office manager reported that a patient received an improperly stored VARIVAX that was reconstituted with properly stored sterile diluent.; This spontaneous report has been received from office manager, regarding to a patient of unknown gender and age. The patient's concomitant therapies, historical conditions and concurrent conditions. On 15-APR-2022, the patient was vaccinated with first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U025791 has been verified to be valid, expiration date 19-AUG-2023) (dose regimen, route of administration and anatomical location were not reported) with properly stored sterile diluent (manufacturer unknown) (lot# and expiration date were not provided) for prophylaxis. Not adverse events (AE) were reported, and no further information was provided. Additionally, it was reported that the varicella virus vaccine live (oka/merck) (VARIVAX)underwent a temperature excursion of 6 Fahrenheit (?F) up to 14 ?F for 15 minutes and 14 ?F up to 46 ?F (average temperature 34.93 ?F) for 1 hours and 15 minutes (product storage error). There was no previous temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2303392

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
NE
Alter
28,0
Geschlecht
F
Eingang
31.05.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect route of product administration

Symptomtext

Pt was given vaccine IM route instead of subcutaneous by ancillary staff. Patient had left clinic at time discovered by this provider reviewing chart/ co-sign so not aware of any symptoms or signs at this time. Called to CDC to verify and per their information the vaccine does not need to be re-administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282631

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
NY
Alter
1,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

No additional AEs or PQC reported.; Caller reports patient received both VARIVAX and PROQUAD on the same day.; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of an unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-MAY-2022, the patient was vaccinated on the same day with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U025791 was confirmed to be valid, expiration date: 19-AUG-2023 (strength not provided), administered for prophylaxis and with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U022726, expiration date: 16-JAN-2023, (strength not provided), administered for prophylaxis (Overdose). No adverse effect was reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2237173

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
16.04.2022
Impfdatum
07.04.2022
Beginn
07.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 07-APR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # u025791 was evaluated and changed to the valid lot # U025791, expiration date: 19-AUG-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes; Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2237172

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
16.04.2022
Impfdatum
07.04.2022
Beginn
07.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; A vaccine coordinator reported VARIVAX was administered after a temperature excursion.; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 07-APR-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (strength, dose and route were not reported; lot # u025791 was evaluated and changed to the valid lot # U025791, expiration date: 19-AUG-2023) for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 11.83 degree Celsius for a time frame of 15 minutes; Previous temperature excursion included 9.37 degree Celsius for a time frame of 2 hours and 30 min. No additional adverse event (AE) information was provided (no adverse event). This is one of the multiple cases reported by the same reporter.; Sender's Comments: US-009507513-2204USA002815:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2225115

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
PR
Alter
-
Geschlecht
U
Eingang
09.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

a patient received a dose of a vaccine that was stored outside of the recommended storage range.; No additional AE reported; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided On an unspecified date, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) valid lot # U025791, expiration date 19-AUG-2023 for prophylaxis (strength, and route of administration were not provided). The vaccine underwent a temperature excursion of -11.3 degree Celsius (C) for a period of 23 hours and 35 minutes (Product storage error). The vaccine did not undergo a previous temperature excursion. The patient did not experience any adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2199864

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
OH
Alter
1,0
Geschlecht
M
Eingang
25.03.2022
Impfdatum
22.03.2022
Beginn
22.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect route of product administration

Symptomtext

MMR vaccine administered intramuscularly in the right thigh, instead of subcutaneously.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2149360

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025791

gering
Staat
IL
Alter
1,3
Geschlecht
M
Eingang
28.02.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Incorrect vaccines given to patient. This error was due to a language barrier and improper double checking/understanding of patient identifiers. Follow up by provider at time of incident, a telephone call/discussion later that afternoon and again 2 days latter. Mother reported no abnormal signs or symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Eczema
Andere Medikamente
Topical: triamcinolone acetonide 0.1% ointment twice daily as needed
Allergien
NKA
Vorherige Impfungen
-